What does it say when a national insurer chooses to follow the science before being forced to by law? This year, Aetna updated its coverage policy to recognize Pediatric Acute-onset Neuropsychiatric ...

Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether ...

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental intranasal therapy reduced brain inflammation and was associated with ...

The approval makes Dupixent the first FDA-approved therapy for allergic fungal rhinosinusitis, supported by Phase III data showing significant improvements in sinus opacification, nasal symptoms, and ...

Explore the groundbreaking developments in pain science reshaping treatment pathways. Dive into the future of managing pain effectively!

Severe infections requiring hospitalization are associated with a markedly increased long-term IBD risk, with immune-related ...

People with allergic fungal rhinosinusitis taking Dupixent saw significant improvement in congestion and sinus inflammation, ...

Turmeric is a spice with antioxidant and anti-inflammatory properties. It may help to treat various types of pain, including joint, muscle, and nerve pain.

The timing of the release aligns with rising public interest in biohacking, stress management, and natural wellness ...

A US basketball player who is struggling with an incurable disease in Indonesian jail has spoken out after avoiding the death penalty ...

InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today key clinical development progress, including the ...

Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...